arrow
M

Maurizio Zazzi

University of Siena
H指数:46
被引数:8,470

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Virological outcomes, resistance profile and viral evolution of lenacapavir-based regimens in heavily treatment-experienced people: data from the PRESTIGIO Registry

病毒学结局、耐药谱和病毒进化:基于lenacapavir的治疗方案在治疗经验丰富的患者中的表现——PRESTIGIO登记研究数据

2026-10-280
OAAI
"The past is never dead; it's not even past"⁎. From EuCARE experience to future pandemics: evidence-based lessons for a prepared Europe

《过去从未死去;它甚至还没有过去》⁎。从EuCARE经验到未来大流行病:为准备充分的欧洲提供的循证教训

2026-10-230
OAAI
Increased in-hospital mortality in immunocompromised individuals hospitalized with COVID-19 during the global pandemic, a multinational cohort study in the EuCARE project

全球大流行期间免疫抑制个体因COVID-19住院期间院内死亡率的增加:EuCARE项目中的多国队列研究

2026-05-080
OA
Evaluation of HIV-1 transmitted drug-resistance among subtypes circulating from 2022 to 2024 in Italy: a refined analysis through next-generation sequencing

2022年至2024年在意大利流行的亚型中HIV-1传播性药物抗性的评估:通过下一代测序进行的精炼分析

2026-03-140
PRE
Anti-cluster A and anti-p24 antibodies in people with multidrug-resistant HIV: preliminary observations from the PRESTIGIO Registry

抗A簇抗体和抗p24抗体在多重耐药HIV感染者中的初步观察:PRESTIGIO登记研究的初步结果

2025-11-030
PRE
96-week real-world effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in HIV-infected adults with pre-existing NRTI resistance: a retrospective cohort study

96周真实世界环境下bictegravir/emtricitabine/tenofovir alafenamide在具有预先存在NRTI耐药的HIV感染者中的有效性:一项回顾性队列研究

2025-10-110
OAAI
Teropavimab and zinlirvimab sensitivity in people living with multidrug-resistant HIV-1: data from the PRESTIGIO Registry

泰罗帕维马单抗和辛利尔维马单抗在合并多药耐药HIV-1感染者中的敏感性:PRESTIGIO登记研究的数据

2025-09-011
OA
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry

评估高治疗经验且多重耐药个体在抑制性抗逆转录病毒治疗下HIV-1 DNA耐药性演化的纵向研究:PRESTIGIO登记研究

2025-09-010
OAAI
Correction: Biba et al. A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations. Viruses 2024, 16, 1465

更正:Biba等人. 对Sanger测序和基于扩增子的下一代测序方法在HIV-1耐药突变检测中的比较研究. Viruses 2024, 16, 1465

2025-08-220
PRE
Comparison of diagnostic performances of HDV RNA quantification assays used in clinical practice: results from a national quality control multicenter study

临床实践中HDV RNA定量检测方法的诊断性能比较:一项国家质量控制多中心研究的结果

2025-08-060
OAAI
Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study)
2025-04-010
PRE
Comparison of diagnostic performances of HDV RNA quantification assays used in clinical practice in Italy: data from the first national quality control multicenter study
2025-03-010
PRE